Motif ID: Elf1_Elf2_Etv2_Elf4
Z-value: 2.931




Transcription factors associated with Elf1_Elf2_Etv2_Elf4:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Elf1 | ENSMUSG00000036461.9 | Elf1 |
Elf2 | ENSMUSG00000037174.12 | Elf2 |
Elf4 | ENSMUSG00000031103.6 | Elf4 |
Etv2 | ENSMUSG00000006311.8 | Etv2 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Elf2 | mm10_v2_chr3_-_51340555_51340584 | -0.71 | 8.9e-04 | Click! |
Elf1 | mm10_v2_chr14_+_79481164_79481194 | -0.60 | 7.9e-03 | Click! |
Elf4 | mm10_v2_chrX_-_48454152_48454193 | 0.17 | 5.1e-01 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 14.3 | GO:0019323 | pentose catabolic process(GO:0019323) |
2.6 | 7.8 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
2.1 | 6.3 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
2.0 | 5.9 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
1.9 | 7.6 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
1.9 | 7.6 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
1.8 | 7.4 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
1.7 | 5.1 | GO:2000043 | regulation of cardiac cell fate specification(GO:2000043) |
1.7 | 5.0 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
1.6 | 4.8 | GO:0070476 | rRNA (guanine-N7)-methylation(GO:0070476) |
1.6 | 9.6 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
1.6 | 6.3 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
1.5 | 10.6 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
1.5 | 4.4 | GO:0051715 | cytolysis in other organism(GO:0051715) |
1.4 | 5.7 | GO:0046061 | dATP catabolic process(GO:0046061) |
1.4 | 5.5 | GO:0030576 | Cajal body organization(GO:0030576) |
1.4 | 1.4 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
1.4 | 8.3 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
1.4 | 28.7 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
1.4 | 4.1 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
1.3 | 5.3 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
1.3 | 3.9 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
1.3 | 5.2 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
1.3 | 5.2 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
1.2 | 7.3 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
1.2 | 6.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
1.2 | 3.6 | GO:0072382 | minus-end-directed vesicle transport along microtubule(GO:0072382) |
1.2 | 4.8 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
1.2 | 1.2 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
1.2 | 1.2 | GO:0043366 | beta selection(GO:0043366) |
1.2 | 3.5 | GO:1990046 | positive regulation of mitochondrial DNA replication(GO:0090297) regulation of cardiolipin metabolic process(GO:1900208) positive regulation of cardiolipin metabolic process(GO:1900210) stress-induced mitochondrial fusion(GO:1990046) |
1.2 | 5.8 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
1.1 | 4.5 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
1.1 | 3.3 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
1.1 | 3.3 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
1.1 | 5.3 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.1 | 1.1 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
1.1 | 2.1 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
1.0 | 4.2 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
1.0 | 4.2 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
1.0 | 3.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
1.0 | 8.3 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
1.0 | 3.0 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
1.0 | 2.9 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
1.0 | 2.9 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
1.0 | 7.7 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
1.0 | 2.9 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
1.0 | 1.0 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
1.0 | 2.9 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.9 | 8.3 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.9 | 2.8 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.9 | 2.8 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.9 | 2.7 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.9 | 5.5 | GO:0021539 | subthalamus development(GO:0021539) |
0.9 | 2.7 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.9 | 3.6 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.9 | 3.5 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.9 | 2.6 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
0.9 | 31.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.8 | 2.5 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.8 | 4.2 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.8 | 0.8 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.8 | 4.1 | GO:0000279 | M phase(GO:0000279) |
0.8 | 21.4 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.8 | 5.7 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.8 | 2.4 | GO:1901355 | response to rapamycin(GO:1901355) |
0.8 | 5.7 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.8 | 4.1 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.8 | 0.8 | GO:0036296 | cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) |
0.8 | 2.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.8 | 0.8 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.8 | 2.4 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.8 | 2.4 | GO:0036292 | DNA rewinding(GO:0036292) |
0.8 | 2.4 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.8 | 0.8 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.8 | 3.8 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.8 | 2.3 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) regulation of eosinophil activation(GO:1902566) |
0.8 | 2.3 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.7 | 7.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.7 | 3.0 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.7 | 4.4 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.7 | 11.8 | GO:0043248 | proteasome assembly(GO:0043248) |
0.7 | 5.1 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.7 | 2.9 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
0.7 | 5.1 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.7 | 3.6 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.7 | 0.7 | GO:0071220 | response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
0.7 | 4.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.7 | 2.1 | GO:1904760 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
0.7 | 2.1 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
0.7 | 4.9 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.7 | 0.7 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.7 | 2.1 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
0.7 | 1.4 | GO:0031126 | snoRNA 3'-end processing(GO:0031126) |
0.7 | 2.1 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.7 | 2.8 | GO:1903416 | response to glycoside(GO:1903416) |
0.7 | 11.7 | GO:0000338 | protein deneddylation(GO:0000338) |
0.7 | 2.1 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.7 | 3.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.7 | 2.7 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.7 | 0.7 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.7 | 2.0 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.7 | 2.7 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.7 | 6.1 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.7 | 1.3 | GO:0009597 | detection of virus(GO:0009597) |
0.7 | 3.3 | GO:1990839 | response to endothelin(GO:1990839) |
0.7 | 0.7 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
0.7 | 2.6 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.7 | 2.0 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.6 | 40.9 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.6 | 1.9 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
0.6 | 6.4 | GO:0051255 | spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
0.6 | 1.3 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.6 | 0.6 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.6 | 3.8 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.6 | 3.8 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.6 | 1.9 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.6 | 1.9 | GO:0015938 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
0.6 | 6.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.6 | 4.4 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.6 | 1.9 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
0.6 | 2.5 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.6 | 0.6 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.6 | 1.2 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
0.6 | 3.6 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.6 | 1.8 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.6 | 3.0 | GO:0046016 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
0.6 | 3.0 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.6 | 1.2 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.6 | 1.2 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
0.6 | 5.2 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.6 | 1.7 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.6 | 1.2 | GO:0044413 | evasion or tolerance of host defenses by virus(GO:0019049) positive regulation of transforming growth factor beta3 production(GO:0032916) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.6 | 10.9 | GO:0045116 | protein neddylation(GO:0045116) |
0.6 | 1.7 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.6 | 0.6 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
0.6 | 2.8 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.6 | 0.6 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.6 | 2.2 | GO:0046073 | dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
0.6 | 1.7 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.6 | 2.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.6 | 1.7 | GO:0010248 | B cell negative selection(GO:0002352) establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.6 | 0.6 | GO:0090005 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.6 | 3.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.6 | 1.7 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.6 | 0.6 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.5 | 2.2 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.5 | 2.7 | GO:0033864 | positive regulation of NAD(P)H oxidase activity(GO:0033864) |
0.5 | 4.9 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.5 | 3.3 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.5 | 4.8 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.5 | 13.5 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.5 | 1.1 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.5 | 1.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.5 | 0.5 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.5 | 0.5 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
0.5 | 2.7 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.5 | 1.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.5 | 2.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.5 | 1.6 | GO:0019043 | establishment of viral latency(GO:0019043) |
0.5 | 2.1 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.5 | 8.4 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.5 | 1.6 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.5 | 1.5 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.5 | 2.1 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.5 | 3.1 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.5 | 7.7 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.5 | 2.6 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
0.5 | 1.5 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.5 | 2.0 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.5 | 0.5 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) |
0.5 | 0.5 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.5 | 6.5 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.5 | 8.6 | GO:0043486 | histone exchange(GO:0043486) |
0.5 | 0.5 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.5 | 2.5 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.5 | 2.0 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) cellular response to lipid hydroperoxide(GO:0071449) |
0.5 | 1.5 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
0.5 | 2.9 | GO:1901970 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.5 | 0.5 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.5 | 5.8 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.5 | 0.5 | GO:0072038 | mesenchymal stem cell maintenance involved in nephron morphogenesis(GO:0072038) |
0.5 | 0.5 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.5 | 0.9 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.5 | 2.4 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.5 | 0.5 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.5 | 3.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.5 | 0.5 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.5 | 1.4 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.5 | 1.4 | GO:0045575 | basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
0.5 | 3.2 | GO:1905216 | positive regulation of RNA binding(GO:1905216) |
0.5 | 1.4 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.5 | 1.8 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.5 | 11.3 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.5 | 4.1 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
0.5 | 2.3 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.5 | 1.4 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.4 | 1.8 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.4 | 2.2 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.4 | 4.0 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.4 | 6.7 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.4 | 1.3 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.4 | 4.0 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.4 | 1.3 | GO:2000319 | negative regulation of T-helper 17 type immune response(GO:2000317) regulation of T-helper 17 cell differentiation(GO:2000319) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.4 | 1.8 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.4 | 1.8 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.4 | 2.2 | GO:0007144 | female meiosis I(GO:0007144) |
0.4 | 12.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.4 | 1.7 | GO:0030091 | protein repair(GO:0030091) |
0.4 | 1.3 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.4 | 0.9 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.4 | 3.4 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.4 | 3.4 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.4 | 5.9 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.4 | 1.3 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.4 | 8.4 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.4 | 2.5 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.4 | 1.7 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.4 | 2.5 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.4 | 2.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.4 | 2.5 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.4 | 0.8 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.4 | 2.1 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.4 | 0.4 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.4 | 2.1 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.4 | 7.0 | GO:0006465 | signal peptide processing(GO:0006465) |
0.4 | 1.2 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.4 | 5.8 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.4 | 0.8 | GO:0097028 | dendritic cell differentiation(GO:0097028) |
0.4 | 2.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.4 | 0.8 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.4 | 0.4 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.4 | 2.5 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
0.4 | 1.2 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.4 | 2.0 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.4 | 2.0 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.4 | 2.4 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.4 | 4.1 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.4 | 1.2 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.4 | 0.8 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.4 | 1.2 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
0.4 | 1.6 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.4 | 1.2 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.4 | 0.8 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.4 | 2.0 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.4 | 2.0 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.4 | 1.6 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.4 | 3.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.4 | 1.6 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.4 | 2.0 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.4 | 12.8 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.4 | 0.8 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.4 | 3.6 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.4 | 3.2 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.4 | 0.4 | GO:0070266 | necroptotic process(GO:0070266) |
0.4 | 7.1 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.4 | 1.6 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.4 | 1.2 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.4 | 0.8 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.4 | 2.7 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.4 | 0.4 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.4 | 1.6 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.4 | 3.1 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.4 | 0.8 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.4 | 1.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.4 | 1.5 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.4 | 3.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.4 | 0.8 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.4 | 2.7 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.4 | 1.9 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.4 | 2.3 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.4 | 1.1 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.4 | 1.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.4 | 1.1 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.4 | 2.6 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.4 | 1.5 | GO:0015786 | UDP-glucose transport(GO:0015786) protein O-linked fucosylation(GO:0036066) |
0.4 | 1.1 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
0.4 | 1.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.4 | 3.4 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.4 | 4.1 | GO:1904851 | positive regulation of establishment of protein localization to telomere(GO:1904851) |
0.4 | 0.7 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.4 | 1.1 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.4 | 2.2 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.4 | 2.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.4 | 1.1 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.4 | 8.8 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.4 | 1.8 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.4 | 1.5 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.4 | 2.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.4 | 0.7 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.4 | 1.1 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.4 | 3.3 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.4 | 2.5 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.4 | 1.1 | GO:0061744 | motor behavior(GO:0061744) |
0.4 | 0.4 | GO:1900044 | regulation of protein K63-linked ubiquitination(GO:1900044) |
0.4 | 1.1 | GO:0016132 | brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
0.4 | 2.9 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.4 | 2.8 | GO:0001842 | neural fold formation(GO:0001842) |
0.4 | 2.1 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.4 | 1.4 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
0.4 | 1.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.4 | 1.4 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.4 | 3.5 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.4 | 1.8 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.3 | 0.7 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.3 | 19.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.3 | 1.4 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.3 | 1.7 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.3 | 1.0 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.3 | 1.0 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.3 | 0.7 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.3 | 3.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.3 | 0.7 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.3 | 2.0 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.3 | 3.0 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.3 | 1.7 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.3 | 2.7 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.3 | 0.3 | GO:0033122 | regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.3 | 0.3 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.3 | 1.0 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
0.3 | 0.7 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.3 | 1.0 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
0.3 | 1.0 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.3 | 1.6 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.3 | 2.3 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.3 | 0.7 | GO:1904705 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
0.3 | 8.4 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.3 | 1.6 | GO:1904721 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.3 | 1.0 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.3 | 2.9 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.3 | 0.6 | GO:1902524 | positive regulation of protein K48-linked ubiquitination(GO:1902524) |
0.3 | 1.9 | GO:0015074 | DNA integration(GO:0015074) |
0.3 | 1.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.3 | 13.5 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.3 | 1.9 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.3 | 1.6 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.3 | 1.9 | GO:0044351 | macropinocytosis(GO:0044351) |
0.3 | 1.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.3 | 3.2 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.3 | 1.3 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.3 | 3.5 | GO:0051451 | myoblast migration(GO:0051451) |
0.3 | 0.9 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.3 | 1.3 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.3 | 3.1 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.3 | 1.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.3 | 0.3 | GO:1902583 | intracellular transport of virus(GO:0075733) multi-organism intracellular transport(GO:1902583) |
0.3 | 0.9 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.3 | 0.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.3 | 0.3 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
0.3 | 2.8 | GO:0006968 | cellular defense response(GO:0006968) |
0.3 | 0.3 | GO:1901224 | activation of NF-kappaB-inducing kinase activity(GO:0007250) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.3 | 7.3 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
0.3 | 2.1 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.3 | 1.8 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.3 | 0.3 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.3 | 3.3 | GO:0060539 | diaphragm development(GO:0060539) |
0.3 | 0.6 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.3 | 1.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 0.6 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.3 | 1.2 | GO:0015825 | L-serine transport(GO:0015825) |
0.3 | 0.3 | GO:0070171 | regulation of tooth mineralization(GO:0070170) negative regulation of tooth mineralization(GO:0070171) |
0.3 | 0.9 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.3 | 27.1 | GO:0006413 | translational initiation(GO:0006413) |
0.3 | 0.9 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.3 | 10.4 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.3 | 0.9 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.3 | 0.9 | GO:0051305 | meiotic chromosome movement towards spindle pole(GO:0016344) chromosome movement towards spindle pole(GO:0051305) |
0.3 | 1.8 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.3 | 8.0 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.3 | 2.7 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.3 | 8.2 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.3 | 0.3 | GO:1990379 | lipid transport across blood brain barrier(GO:1990379) |
0.3 | 0.9 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.3 | 5.8 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 1.5 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.3 | 2.0 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.3 | 2.3 | GO:0006560 | proline metabolic process(GO:0006560) |
0.3 | 1.4 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.3 | 0.9 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.3 | 4.0 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.3 | 1.7 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.3 | 1.4 | GO:1903232 | melanosome assembly(GO:1903232) |
0.3 | 0.8 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.3 | 0.6 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.3 | 1.7 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.3 | 7.0 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.3 | 1.7 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.3 | 0.3 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.3 | 7.8 | GO:0006284 | base-excision repair(GO:0006284) |
0.3 | 1.7 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.3 | 2.2 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.3 | 0.8 | GO:0090656 | t-circle formation(GO:0090656) |
0.3 | 0.8 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.3 | 0.8 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.3 | 2.2 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.3 | 0.6 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.3 | 0.5 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) positive regulation of neuromuscular junction development(GO:1904398) |
0.3 | 5.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.3 | 0.8 | GO:0051030 | snRNA transport(GO:0051030) |
0.3 | 0.5 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.3 | 0.5 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.3 | 0.8 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.3 | 13.1 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.3 | 3.7 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.3 | 1.1 | GO:0070166 | enamel mineralization(GO:0070166) |
0.3 | 1.3 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.3 | 1.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.3 | 0.8 | GO:0001887 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
0.3 | 0.5 | GO:0048478 | replication fork protection(GO:0048478) |
0.3 | 1.0 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.3 | 3.1 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.3 | 2.3 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.3 | 1.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.3 | 5.7 | GO:0042775 | mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
0.3 | 2.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) embryonic hindgut morphogenesis(GO:0048619) |
0.3 | 0.5 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.3 | 3.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.3 | 1.8 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.3 | 1.8 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 2.0 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.3 | 1.3 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.3 | 0.8 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.3 | 0.8 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.3 | 3.0 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.3 | 1.3 | GO:0051461 | regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.3 | 0.5 | GO:0035547 | interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) |
0.3 | 0.3 | GO:0003263 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
0.3 | 0.8 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.3 | 1.5 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 0.7 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.2 | 0.5 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.2 | 0.7 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.2 | 1.2 | GO:0015867 | ATP transport(GO:0015867) |
0.2 | 0.7 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.2 | 1.2 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 0.2 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.2 | 0.5 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.2 | 0.7 | GO:0019062 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
0.2 | 0.5 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 3.2 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.2 | 1.4 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 1.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.2 | 0.7 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
0.2 | 0.2 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.2 | 1.0 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.2 | 0.7 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.2 | 1.7 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.5 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.2 | 5.2 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 2.3 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.2 | 0.7 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.2 | 2.3 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.2 | 1.2 | GO:0061450 | trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) |
0.2 | 1.4 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.2 | 0.9 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
0.2 | 0.2 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.2 | 1.4 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 0.7 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 8.9 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.2 | 0.7 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.2 | 1.1 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.2 | 0.7 | GO:0051309 | female meiosis chromosome segregation(GO:0016321) female meiosis chromosome separation(GO:0051309) |
0.2 | 0.7 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.2 | 1.4 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 0.9 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.2 | 1.1 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.2 | 0.9 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 0.9 | GO:0048241 | epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
0.2 | 1.8 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.2 | 1.3 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.2 | 0.7 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.2 | 0.2 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.2 | 0.4 | GO:0046671 | negative regulation of retinal cell programmed cell death(GO:0046671) |
0.2 | 0.9 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.2 | 0.7 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.2 | 0.4 | GO:0002551 | mast cell chemotaxis(GO:0002551) mast cell migration(GO:0097531) |
0.2 | 0.9 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.2 | 2.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 69.0 | GO:0008380 | RNA splicing(GO:0008380) |
0.2 | 0.7 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.2 | 2.6 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 1.5 | GO:0032506 | cytokinetic process(GO:0032506) |
0.2 | 0.4 | GO:0015675 | nickel cation transport(GO:0015675) |
0.2 | 0.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 7.6 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.2 | 1.7 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.2 | 0.4 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.2 | 1.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.6 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.2 | 0.6 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.2 | 2.8 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.2 | 0.8 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.2 | 1.3 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.2 | 0.2 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.2 | 0.4 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.2 | 0.2 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.2 | 1.4 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.2 | 0.6 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.2 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 0.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 0.4 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.2 | 0.2 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.2 | 1.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.2 | 5.3 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.2 | 0.8 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 0.6 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.2 | 1.4 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.2 | 0.8 | GO:0050904 | diapedesis(GO:0050904) |
0.2 | 1.2 | GO:0072081 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) |
0.2 | 0.4 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
0.2 | 0.4 | GO:0061110 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
0.2 | 4.3 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.2 | 0.4 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.2 | 0.4 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.2 | 0.4 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.2 | 2.5 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.2 | 0.8 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.2 | 0.6 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.2 | 1.3 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.2 | 1.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.2 | 2.3 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.2 | 2.7 | GO:0042832 | response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
0.2 | 0.9 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.2 | 0.6 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.2 | 0.6 | GO:1903311 | regulation of mRNA metabolic process(GO:1903311) |
0.2 | 1.1 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.2 | 0.9 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.2 | 0.6 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
0.2 | 0.6 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.2 | 0.6 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.2 | 1.7 | GO:0021678 | third ventricle development(GO:0021678) |
0.2 | 2.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 2.4 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.2 | 0.5 | GO:0051591 | response to cAMP(GO:0051591) |
0.2 | 1.6 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.2 | 1.3 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.2 | 0.5 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
0.2 | 0.7 | GO:0061743 | motor learning(GO:0061743) |
0.2 | 0.5 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
0.2 | 0.5 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.2 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 0.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 2.0 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 1.1 | GO:0006760 | folic acid-containing compound metabolic process(GO:0006760) pteridine-containing compound metabolic process(GO:0042558) |
0.2 | 1.2 | GO:0097421 | liver regeneration(GO:0097421) |
0.2 | 0.2 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.2 | 0.5 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.2 | 1.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 1.0 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.2 | 0.5 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
0.2 | 1.0 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.2 | 0.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 1.0 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.2 | 5.1 | GO:0007566 | embryo implantation(GO:0007566) |
0.2 | 2.4 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.2 | 0.5 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.2 | 1.2 | GO:0060179 | male mating behavior(GO:0060179) |
0.2 | 1.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 1.0 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.2 | 1.3 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.2 | 0.2 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.2 | 0.7 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 0.7 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 0.7 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.2 | 0.5 | GO:0021759 | globus pallidus development(GO:0021759) |
0.2 | 0.6 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.2 | 0.3 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.2 | 0.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 2.3 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.2 | 0.2 | GO:0034204 | lipid translocation(GO:0034204) |
0.2 | 0.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.2 | 0.3 | GO:0045358 | negative regulation of interferon-beta biosynthetic process(GO:0045358) |
0.2 | 1.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.2 | 1.6 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.2 | 0.9 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.2 | 0.5 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
0.2 | 0.3 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.2 | 0.6 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.2 | 0.3 | GO:0001803 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.2 | 0.8 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.2 | 2.0 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.2 | 0.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 1.7 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.2 | 0.5 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.2 | 0.5 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.2 | 0.6 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.2 | 4.5 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.2 | 2.3 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.2 | 0.8 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.2 | 4.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.9 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.1 | 0.3 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.1 | 0.4 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 0.4 | GO:0048289 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.1 | 0.9 | GO:2000192 | negative regulation of fatty acid transport(GO:2000192) |
0.1 | 0.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.1 | 0.9 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.7 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 0.7 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.1 | 2.3 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.9 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.7 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.4 | GO:0045766 | positive regulation of angiogenesis(GO:0045766) |
0.1 | 0.7 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.9 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.1 | 0.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.3 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.1 | 0.3 | GO:0090646 | mitochondrial RNA 3'-end processing(GO:0000965) mitochondrial tRNA processing(GO:0090646) |
0.1 | 0.6 | GO:0007320 | insemination(GO:0007320) |
0.1 | 1.7 | GO:1903019 | negative regulation of glycoprotein metabolic process(GO:1903019) |
0.1 | 0.3 | GO:0045765 | regulation of angiogenesis(GO:0045765) |
0.1 | 0.8 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.7 | GO:0002828 | regulation of type 2 immune response(GO:0002828) |
0.1 | 0.3 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
0.1 | 0.1 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.1 | 0.3 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.4 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 0.8 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.1 | 0.4 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.1 | 0.4 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.1 | 0.1 | GO:1904170 | regulation of bleb assembly(GO:1904170) |
0.1 | 0.9 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 0.8 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.1 | 0.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.8 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.3 | GO:0044241 | lipid digestion(GO:0044241) |
0.1 | 0.4 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.1 | 3.5 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.4 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.1 | 0.5 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.1 | 0.3 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
0.1 | 0.6 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.4 | GO:0019389 | urate transport(GO:0015747) glucuronoside metabolic process(GO:0019389) negative regulation of intestinal absorption(GO:1904479) |
0.1 | 0.1 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 1.4 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 1.0 | GO:0002118 | aggressive behavior(GO:0002118) |
0.1 | 0.4 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.1 | 3.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.4 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.3 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.1 | 0.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.4 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.4 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 0.5 | GO:0098534 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.1 | 0.1 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
0.1 | 0.5 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.1 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.2 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.1 | 0.1 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
0.1 | 1.4 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 | 0.4 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.1 | 0.2 | GO:0010920 | negative regulation of inositol phosphate biosynthetic process(GO:0010920) regulation of testosterone biosynthetic process(GO:2000224) |
0.1 | 0.2 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.1 | 3.2 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.1 | 0.1 | GO:2000643 | positive regulation of vacuolar transport(GO:1903337) positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 1.3 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 2.6 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.6 | GO:0072217 | mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003337) negative regulation of metanephros development(GO:0072217) |
0.1 | 0.2 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 1.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.2 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 0.8 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.1 | 2.0 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.3 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.3 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.1 | 0.2 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.1 | 0.8 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 0.2 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.1 | 0.3 | GO:0050779 | RNA destabilization(GO:0050779) |
0.1 | 1.1 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.1 | 2.8 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 0.6 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.1 | 0.3 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.1 | 0.2 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.1 | 0.2 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 0.8 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 0.1 | GO:0061009 | common bile duct development(GO:0061009) |
0.1 | 0.7 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.2 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.1 | 1.1 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.1 | 0.1 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 2.0 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 1.1 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.2 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.1 | 0.4 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.5 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.1 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 1.8 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 2.7 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.1 | 0.5 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.1 | 1.3 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 3.6 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.5 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.1 | 0.3 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.1 | 0.4 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.1 | 0.3 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 27.7 | GO:0006412 | translation(GO:0006412) |
0.1 | 0.4 | GO:0042773 | ATP synthesis coupled electron transport(GO:0042773) |
0.1 | 0.8 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.1 | 2.2 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.1 | 0.8 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.1 | 2.6 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 0.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.9 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.3 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.1 | 0.8 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 0.4 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.5 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.1 | 0.3 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.1 | 0.9 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.2 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.1 | 0.2 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.1 | 0.1 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.1 | 0.3 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.1 | 0.3 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
0.1 | 0.5 | GO:0048864 | stem cell development(GO:0048864) |
0.1 | 0.3 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 1.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 1.5 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 1.5 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.6 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 1.5 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.1 | 0.3 | GO:0060217 | positive regulation of chromatin assembly or disassembly(GO:0045799) hemangioblast cell differentiation(GO:0060217) regulation of mast cell differentiation(GO:0060375) |
0.1 | 0.6 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 0.7 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.1 | 0.3 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.3 | GO:0006788 | heme oxidation(GO:0006788) |
0.1 | 0.4 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 0.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.2 | GO:2000232 | regulation of rRNA processing(GO:2000232) |
0.1 | 8.4 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
0.1 | 0.4 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 1.3 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.1 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 0.3 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 1.1 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.3 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.4 | GO:0001914 | regulation of T cell mediated cytotoxicity(GO:0001914) |
0.1 | 0.2 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.1 | 0.7 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.4 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 0.4 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 2.7 | GO:0001885 | endothelial cell development(GO:0001885) |
0.1 | 2.6 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 0.2 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.1 | 0.1 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.1 | 0.1 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.1 | 0.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.1 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.1 | 0.5 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.4 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.3 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.1 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.1 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) |
0.1 | 0.1 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.1 | 0.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.4 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.1 | 0.1 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.1 | 0.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.4 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.3 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.1 | 0.1 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.1 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.3 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.1 | 0.7 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.3 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.9 | GO:0001946 | lymphangiogenesis(GO:0001946) |
0.1 | 0.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.3 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.1 | 0.1 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.1 | 0.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 2.5 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.6 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.2 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 0.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.1 | 1.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.1 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
0.1 | 0.6 | GO:1903671 | negative regulation of sprouting angiogenesis(GO:1903671) |
0.1 | 2.3 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.1 | 0.7 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.4 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.2 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.1 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.1 | 1.6 | GO:0007097 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.1 | 0.7 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.3 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.1 | 0.7 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.1 | 0.1 | GO:0033084 | immature T cell proliferation(GO:0033079) immature T cell proliferation in thymus(GO:0033080) regulation of immature T cell proliferation(GO:0033083) regulation of immature T cell proliferation in thymus(GO:0033084) |
0.1 | 0.2 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 3.2 | GO:1901343 | negative regulation of vasculature development(GO:1901343) |
0.1 | 1.0 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.1 | 0.1 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) oxidative demethylation(GO:0070989) |
0.1 | 1.1 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 0.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 2.8 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.1 | 0.2 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.1 | 0.4 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.1 | 0.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.9 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.1 | 0.4 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.4 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.2 | GO:0071356 | cellular response to tumor necrosis factor(GO:0071356) |
0.1 | 0.4 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.2 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.1 | 0.4 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.1 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.1 | 0.6 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 0.2 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.1 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.1 | 0.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.2 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 0.4 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.4 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.2 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 2.0 | GO:0042168 | heme metabolic process(GO:0042168) |
0.1 | 0.4 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 0.1 | GO:1903010 | regulation of bone development(GO:1903010) |
0.1 | 0.3 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.1 | 0.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.1 | 0.2 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of postsynaptic membrane organization(GO:1901628) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.1 | 0.3 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.1 | 0.3 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.1 | 0.1 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.1 | 0.4 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.3 | GO:0071281 | cellular response to iron ion(GO:0071281) |
0.1 | 1.1 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.4 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
0.1 | 0.5 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 0.2 | GO:0001945 | lymph vessel development(GO:0001945) |
0.1 | 1.7 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.5 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.1 | 0.4 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.3 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.1 | 1.9 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.3 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 0.7 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.3 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.1 | 0.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.4 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 0.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.2 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.1 | 0.4 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.1 | 1.0 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.1 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.1 | 0.4 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
0.1 | 0.4 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.2 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.4 | GO:0015862 | uridine transport(GO:0015862) pyrimidine nucleoside transport(GO:0015864) |
0.1 | 0.5 | GO:0042053 | regulation of dopamine metabolic process(GO:0042053) regulation of catecholamine metabolic process(GO:0042069) |
0.1 | 0.3 | GO:0070836 | caveola assembly(GO:0070836) |
0.1 | 0.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.9 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.1 | 0.2 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 0.2 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.1 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.1 | 0.3 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
0.1 | 0.2 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.1 | 0.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.4 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.1 | 0.2 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.1 | GO:0002701 | negative regulation of production of molecular mediator of immune response(GO:0002701) |
0.1 | 0.2 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.1 | 1.0 | GO:0071229 | cellular response to acid chemical(GO:0071229) |
0.1 | 0.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 0.1 | GO:0051004 | regulation of lipoprotein lipase activity(GO:0051004) |
0.1 | 1.7 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.1 | 0.2 | GO:0009451 | RNA modification(GO:0009451) |
0.1 | 0.2 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.1 | 0.2 | GO:0072576 | liver morphogenesis(GO:0072576) |
0.1 | 0.2 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
0.0 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.2 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.0 | 0.3 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.0 | 0.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.2 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.0 | 0.3 | GO:0021534 | cell proliferation in hindbrain(GO:0021534) |
0.0 | 0.1 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.0 | 0.3 | GO:2000177 | regulation of neural precursor cell proliferation(GO:2000177) |
0.0 | 0.7 | GO:0051298 | centrosome duplication(GO:0051298) |
0.0 | 0.4 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.0 | 0.2 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.0 | 0.5 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.0 | 0.4 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.0 | 1.4 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 0.1 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) endoplasmic reticulum mannose trimming(GO:1904380) |
0.0 | 1.2 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.0 | 0.2 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.0 | 0.0 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.0 | 0.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.0 | 0.0 | GO:0048730 | hair follicle morphogenesis(GO:0031069) epidermis morphogenesis(GO:0048730) |
0.0 | 0.2 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.0 | 0.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 1.8 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) |
0.0 | 0.2 | GO:0046148 | pigment biosynthetic process(GO:0046148) |
0.0 | 1.7 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.0 | 0.1 | GO:0071637 | monocyte chemotactic protein-1 production(GO:0071605) regulation of monocyte chemotactic protein-1 production(GO:0071637) |
0.0 | 0.3 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.0 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.0 | 0.0 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.0 | 0.1 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.0 | 0.1 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
0.0 | 0.1 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.0 | 0.2 | GO:0010712 | regulation of collagen metabolic process(GO:0010712) |
0.0 | 0.4 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.0 | 0.2 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.0 | 0.2 | GO:0072376 | protein activation cascade(GO:0072376) |
0.0 | 0.1 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.0 | 0.1 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.0 | 0.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.2 | GO:1901070 | guanosine-containing compound biosynthetic process(GO:1901070) |
0.0 | 0.6 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.0 | 0.5 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.1 | GO:1905245 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.0 | 0.1 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.0 | 0.0 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.0 | 0.2 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 0.9 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 0.1 | GO:0009814 | defense response, incompatible interaction(GO:0009814) |
0.0 | 0.1 | GO:0046794 | transport of virus(GO:0046794) |
0.0 | 0.2 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 1.3 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.1 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.0 | 0.1 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.0 | 0.1 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.9 | GO:0009060 | aerobic respiration(GO:0009060) |
0.0 | 0.2 | GO:0048636 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.0 | 0.9 | GO:0042476 | odontogenesis(GO:0042476) |
0.0 | 0.1 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 0.1 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.0 | 0.0 | GO:0051665 | membrane raft localization(GO:0051665) |
0.0 | 0.1 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 0.1 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.0 | 0.2 | GO:0030035 | microspike assembly(GO:0030035) |
0.0 | 0.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.0 | 0.1 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.0 | 0.1 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.1 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 0.7 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.1 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.2 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.3 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.0 | 0.3 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.3 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.4 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.0 | 0.1 | GO:0042730 | fibrinolysis(GO:0042730) |
0.0 | 0.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.0 | 0.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.0 | GO:0009410 | response to xenobiotic stimulus(GO:0009410) |
0.0 | 0.1 | GO:1902219 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.0 | 0.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.0 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.1 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.0 | 0.3 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.0 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.3 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.0 | 0.1 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.0 | 0.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.7 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.4 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.4 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.1 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.0 | 0.1 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.0 | 0.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.5 | GO:0051180 | vitamin transport(GO:0051180) |
0.0 | 0.0 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.1 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.0 | 0.0 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 0.2 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.0 | 0.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.2 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.2 | GO:0022900 | electron transport chain(GO:0022900) |
0.0 | 0.3 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.0 | 0.0 | GO:0098586 | cellular response to virus(GO:0098586) |
0.0 | 0.1 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.0 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 | 0.3 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.0 | 0.1 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 0.3 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.1 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.0 | 0.1 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
0.0 | 0.2 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.0 | 0.3 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.0 | 0.1 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.0 | 0.1 | GO:0015669 | gas transport(GO:0015669) |
0.0 | 0.0 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.2 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.4 | GO:0042307 | positive regulation of protein import into nucleus(GO:0042307) |
0.0 | 0.0 | GO:0045606 | positive regulation of epidermal cell differentiation(GO:0045606) |
0.0 | 0.2 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.0 | 0.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.3 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.3 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 0.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.3 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.0 | 0.1 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.1 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.0 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.0 | 0.1 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.0 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.0 | 0.0 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.0 | 0.0 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.1 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.1 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.0 | 0.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.0 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
0.0 | 0.2 | GO:0051225 | spindle assembly(GO:0051225) |
0.0 | 0.0 | GO:0050667 | sulfur amino acid metabolic process(GO:0000096) homocysteine metabolic process(GO:0050667) |
0.0 | 0.1 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.0 | 0.1 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) |
0.0 | 0.0 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.4 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
2.4 | 7.1 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
2.0 | 2.0 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
1.8 | 22.1 | GO:0005687 | U4 snRNP(GO:0005687) |
1.7 | 1.7 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
1.6 | 4.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
1.6 | 1.6 | GO:0035061 | interchromatin granule(GO:0035061) |
1.5 | 10.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
1.5 | 13.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
1.4 | 4.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
1.4 | 5.4 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
1.3 | 13.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
1.3 | 1.3 | GO:0035101 | FACT complex(GO:0035101) |
1.3 | 3.8 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.3 | 5.0 | GO:0001651 | dense fibrillar component(GO:0001651) |
1.2 | 6.0 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
1.1 | 3.3 | GO:0071953 | elastic fiber(GO:0071953) |
1.1 | 3.2 | GO:0000801 | central element(GO:0000801) |
1.1 | 56.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
1.0 | 4.1 | GO:0031298 | replication fork protection complex(GO:0031298) |
1.0 | 8.8 | GO:0005688 | U6 snRNP(GO:0005688) |
1.0 | 70.3 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.9 | 8.4 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.9 | 8.3 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.9 | 2.8 | GO:0018444 | translation release factor complex(GO:0018444) |
0.9 | 1.8 | GO:0097346 | INO80-type complex(GO:0097346) |
0.9 | 8.0 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.9 | 7.9 | GO:0072687 | meiotic spindle(GO:0072687) |
0.9 | 9.6 | GO:0005642 | annulate lamellae(GO:0005642) |
0.9 | 5.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.8 | 5.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.8 | 2.5 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.8 | 3.3 | GO:0034709 | methylosome(GO:0034709) |
0.8 | 4.0 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.8 | 2.4 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.8 | 3.2 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.8 | 9.5 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.8 | 7.8 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.8 | 2.3 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.8 | 5.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.8 | 6.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.8 | 2.3 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.8 | 5.3 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.7 | 3.0 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.7 | 10.4 | GO:0000974 | Prp19 complex(GO:0000974) |
0.7 | 2.9 | GO:0070552 | BRISC complex(GO:0070552) |
0.7 | 3.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.7 | 2.1 | GO:0071914 | prominosome(GO:0071914) |
0.7 | 2.1 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
0.7 | 9.6 | GO:0042555 | MCM complex(GO:0042555) |
0.7 | 0.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.7 | 4.0 | GO:0034448 | EGO complex(GO:0034448) |
0.7 | 4.6 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.6 | 9.7 | GO:0031011 | Ino80 complex(GO:0031011) |
0.6 | 4.5 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.6 | 3.9 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.6 | 3.2 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.6 | 4.5 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.6 | 2.5 | GO:0035339 | SPOTS complex(GO:0035339) |
0.6 | 4.8 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.6 | 2.4 | GO:0008623 | CHRAC(GO:0008623) |
0.6 | 2.4 | GO:0060187 | cell pole(GO:0060187) |
0.6 | 1.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.6 | 5.8 | GO:0016272 | prefoldin complex(GO:0016272) |
0.6 | 10.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.6 | 4.6 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.6 | 3.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.6 | 5.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.6 | 4.6 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.6 | 9.1 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.6 | 1.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.6 | 2.3 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.6 | 1.7 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
0.6 | 6.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.6 | 33.2 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.6 | 1.7 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.5 | 0.5 | GO:0016600 | flotillin complex(GO:0016600) |
0.5 | 2.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.5 | 1.6 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.5 | 6.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.5 | 0.5 | GO:0090537 | CERF complex(GO:0090537) |
0.5 | 2.1 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.5 | 6.7 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.5 | 4.1 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.5 | 4.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.5 | 3.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.5 | 6.0 | GO:0043219 | lateral loop(GO:0043219) |
0.5 | 4.5 | GO:0030686 | 90S preribosome(GO:0030686) |
0.5 | 5.4 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.5 | 2.9 | GO:0071817 | MMXD complex(GO:0071817) |
0.5 | 1.5 | GO:0000243 | commitment complex(GO:0000243) |
0.5 | 11.0 | GO:0005839 | proteasome core complex(GO:0005839) |
0.5 | 13.0 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.5 | 5.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.5 | 3.7 | GO:0005818 | aster(GO:0005818) |
0.5 | 2.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.5 | 2.7 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.5 | 1.8 | GO:0032021 | NELF complex(GO:0032021) |
0.5 | 11.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.4 | 5.8 | GO:0016589 | NURF complex(GO:0016589) |
0.4 | 13.4 | GO:0044391 | ribosomal subunit(GO:0044391) |
0.4 | 4.0 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.4 | 2.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.4 | 1.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.4 | 6.5 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.4 | 0.9 | GO:0044299 | C-fiber(GO:0044299) |
0.4 | 2.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.4 | 2.6 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.4 | 20.1 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.4 | 2.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.4 | 4.7 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.4 | 1.3 | GO:0044439 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.4 | 10.6 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.4 | 1.3 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.4 | 5.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.4 | 2.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.4 | 1.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.4 | 1.2 | GO:0031417 | NatC complex(GO:0031417) |
0.4 | 6.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.4 | 3.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.4 | 5.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.4 | 2.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.4 | 4.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.4 | 0.4 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.4 | 4.7 | GO:0005686 | U2 snRNP(GO:0005686) |
0.4 | 6.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.4 | 4.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.4 | 11.6 | GO:0032040 | small-subunit processome(GO:0032040) |
0.4 | 1.2 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.4 | 1.5 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.4 | 17.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.4 | 2.3 | GO:0005876 | spindle microtubule(GO:0005876) |
0.4 | 6.4 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.4 | 1.5 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.4 | 3.7 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.4 | 0.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.4 | 2.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.4 | 0.7 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.4 | 0.7 | GO:0016514 | SWI/SNF complex(GO:0016514) npBAF complex(GO:0071564) |
0.3 | 2.4 | GO:0008278 | cohesin complex(GO:0008278) |
0.3 | 1.4 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.3 | 1.4 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.3 | 5.2 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.3 | 1.0 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.3 | 7.4 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.3 | 1.7 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.3 | 1.3 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.3 | 1.7 | GO:0033010 | paranodal junction(GO:0033010) |
0.3 | 3.7 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.3 | 1.0 | GO:1990423 | RZZ complex(GO:1990423) |
0.3 | 1.0 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.3 | 2.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 2.6 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.3 | 1.6 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.3 | 0.6 | GO:0001652 | granular component(GO:0001652) |
0.3 | 1.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 27.7 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.3 | 5.6 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.3 | 1.2 | GO:0071942 | XPC complex(GO:0071942) |
0.3 | 0.9 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.3 | 2.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 0.9 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.3 | 6.9 | GO:0015030 | Cajal body(GO:0015030) |
0.3 | 0.3 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
0.3 | 1.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.3 | 1.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 1.8 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.3 | 2.4 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.3 | 3.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.3 | 2.9 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.3 | 1.1 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.3 | 2.0 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.3 | 2.5 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.3 | 3.0 | GO:0005915 | zonula adherens(GO:0005915) |
0.3 | 0.8 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.3 | 5.6 | GO:0001741 | XY body(GO:0001741) |
0.3 | 2.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 1.6 | GO:0071986 | Ragulator complex(GO:0071986) |
0.3 | 0.3 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.3 | 1.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.3 | 7.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.3 | 2.9 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.3 | 0.3 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.3 | 1.5 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 1.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 1.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 1.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 2.2 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 2.5 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 0.5 | GO:0070069 | cytochrome complex(GO:0070069) |
0.2 | 1.0 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.2 | 5.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 7.7 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.2 | 2.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 1.4 | GO:0070187 | telosome(GO:0070187) |
0.2 | 3.9 | GO:0016460 | myosin II complex(GO:0016460) |
0.2 | 4.1 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.2 | 1.6 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.2 | 0.2 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.2 | 16.3 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.2 | 1.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 0.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.2 | 11.7 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 3.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 2.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 3.3 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 0.9 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 0.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 3.5 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 1.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.2 | 2.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 4.7 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.2 | 1.9 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.2 | 0.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 3.6 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 0.6 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 4.5 | GO:0038201 | TOR complex(GO:0038201) |
0.2 | 0.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 0.8 | GO:0043259 | laminin-1 complex(GO:0005606) laminin-10 complex(GO:0043259) |
0.2 | 3.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 3.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 0.8 | GO:0016580 | Sin3 complex(GO:0016580) |
0.2 | 0.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 0.8 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 1.8 | GO:0061617 | MICOS complex(GO:0061617) |
0.2 | 0.6 | GO:1990047 | spindle matrix(GO:1990047) |
0.2 | 1.8 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.2 | 1.0 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 0.8 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.2 | 0.6 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.2 | 1.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 1.5 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 2.1 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.2 | 1.7 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 1.8 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 0.9 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.2 | 0.9 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 6.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.2 | 0.5 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 1.0 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
0.2 | 1.9 | GO:0070469 | respiratory chain(GO:0070469) |
0.2 | 9.0 | GO:0005871 | kinesin complex(GO:0005871) |
0.2 | 3.0 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.2 | 1.3 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 0.3 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 1.1 | GO:0090544 | BAF-type complex(GO:0090544) |
0.2 | 1.4 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.2 | 0.8 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 0.8 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 3.4 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.1 | 1.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.6 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.1 | 0.9 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.7 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 1.0 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.6 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 1.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 2.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 1.1 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.1 | 0.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.6 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 5.3 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 2.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 1.4 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.4 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.1 | 1.9 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.1 | 0.1 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.1 | 0.1 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.1 | 0.3 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 1.8 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.4 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.1 | 1.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 7.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 5.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.7 | GO:0098858 | actin-based cell projection(GO:0098858) |
0.1 | 0.4 | GO:0031251 | PAN complex(GO:0031251) |
0.1 | 0.4 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
0.1 | 1.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.5 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 1.6 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 0.6 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 1.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 1.0 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 3.0 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 30.3 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 1.0 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.4 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 1.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 1.7 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.1 | 0.8 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.6 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.4 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 1.5 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 29.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 1.2 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.3 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 0.6 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 1.8 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.3 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
0.1 | 2.9 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 6.6 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.3 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.1 | 1.5 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 2.3 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.1 | 0.8 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.8 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.2 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 0.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.3 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.1 | 0.3 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.1 | 0.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.6 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 0.6 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 1.6 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 2.6 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 3.0 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 1.3 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 0.8 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 0.7 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 0.5 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 4.6 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 4.0 | GO:0036126 | sperm flagellum(GO:0036126) |
0.1 | 1.4 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 0.7 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.1 | GO:0098842 | postsynaptic early endosome(GO:0098842) |
0.1 | 2.9 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 0.8 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.2 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 2.6 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.3 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 1.3 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 2.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.5 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 3.5 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.5 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.0 | 0.1 | GO:0097444 | spine apparatus(GO:0097444) |
0.0 | 3.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 0.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.3 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.1 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.0 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.0 | GO:0097361 | CIA complex(GO:0097361) |
0.0 | 0.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.0 | 0.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.1 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.0 | 0.1 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.0 | 0.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 0.7 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.1 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.0 | 0.6 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 1.2 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.2 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.0 | 0.5 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.1 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 6.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.3 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 4.4 | GO:0005740 | mitochondrial envelope(GO:0005740) |
0.0 | 0.4 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.3 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 1.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.4 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.0 | 0.8 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.3 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 1.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.1 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.0 | 21.0 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 13.4 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 1.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.1 | GO:0036464 | cytoplasmic ribonucleoprotein granule(GO:0036464) |
0.0 | 0.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.0 | 0.2 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 0.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.5 | GO:0034399 | nuclear periphery(GO:0034399) |
0.0 | 0.5 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.0 | 0.5 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.8 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 10.1 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
2.0 | 18.4 | GO:1990446 | U1 snRNP binding(GO:1990446) |
1.8 | 5.5 | GO:0070140 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
1.8 | 5.3 | GO:0004335 | galactokinase activity(GO:0004335) |
1.6 | 6.5 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
1.6 | 3.2 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
1.5 | 7.6 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
1.5 | 3.0 | GO:0070990 | snRNP binding(GO:0070990) |
1.5 | 4.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
1.4 | 1.4 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
1.4 | 10.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
1.4 | 4.2 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
1.3 | 4.0 | GO:0005110 | frizzled-2 binding(GO:0005110) |
1.3 | 5.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
1.3 | 12.6 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
1.3 | 6.3 | GO:0042610 | CD8 receptor binding(GO:0042610) |
1.2 | 4.9 | GO:0046923 | ER retention sequence binding(GO:0046923) |
1.2 | 6.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
1.1 | 14.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
1.1 | 9.1 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
1.1 | 4.5 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
1.1 | 3.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
1.0 | 3.1 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
1.0 | 5.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
1.0 | 5.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
1.0 | 3.0 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
1.0 | 13.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
1.0 | 10.6 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
1.0 | 6.7 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
1.0 | 5.7 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.9 | 3.8 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.9 | 3.8 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.9 | 3.7 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.9 | 6.4 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.9 | 3.6 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.9 | 3.6 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.9 | 2.7 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.9 | 7.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.8 | 134.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.8 | 4.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.8 | 2.4 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.8 | 6.4 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.8 | 8.8 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.8 | 3.2 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.8 | 2.4 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.8 | 2.4 | GO:0098973 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
0.8 | 3.1 | GO:0030984 | kininogen binding(GO:0030984) |
0.8 | 7.7 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.8 | 2.3 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.8 | 2.3 | GO:0071568 | UFM1 transferase activity(GO:0071568) |
0.7 | 6.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.7 | 21.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.7 | 5.7 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.7 | 2.8 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
0.7 | 2.1 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.7 | 6.9 | GO:0050733 | RS domain binding(GO:0050733) |
0.7 | 11.8 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.7 | 2.1 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.7 | 0.7 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.6 | 3.2 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.6 | 1.9 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.6 | 3.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.6 | 1.8 | GO:0030911 | TPR domain binding(GO:0030911) |
0.6 | 3.6 | GO:0000339 | RNA cap binding(GO:0000339) |
0.6 | 5.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.6 | 1.8 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.6 | 1.8 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.6 | 12.8 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.6 | 4.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.6 | 5.8 | GO:0015266 | protein channel activity(GO:0015266) |
0.6 | 2.3 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.6 | 36.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.6 | 4.5 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.6 | 1.7 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.6 | 2.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.6 | 1.7 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.6 | 3.9 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.5 | 1.6 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.5 | 2.2 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.5 | 2.2 | GO:0042806 | fucose binding(GO:0042806) |
0.5 | 2.2 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.5 | 2.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.5 | 7.5 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.5 | 3.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.5 | 5.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.5 | 0.5 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.5 | 3.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.5 | 2.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.5 | 2.6 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.5 | 2.5 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.5 | 6.5 | GO:0031386 | protein tag(GO:0031386) |
0.5 | 3.0 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.5 | 1.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.5 | 2.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.5 | 1.5 | GO:0030172 | troponin C binding(GO:0030172) |
0.5 | 1.5 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.5 | 2.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.5 | 3.9 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.5 | 1.0 | GO:0030519 | snoRNP binding(GO:0030519) |
0.5 | 1.4 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.5 | 1.9 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.5 | 2.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.5 | 1.9 | GO:0035877 | death effector domain binding(GO:0035877) |
0.5 | 1.4 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
0.5 | 13.2 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.5 | 1.4 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.5 | 3.3 | GO:0008430 | selenium binding(GO:0008430) |
0.5 | 2.8 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.5 | 0.5 | GO:0070699 | receptor serine/threonine kinase binding(GO:0033612) transmembrane receptor protein serine/threonine kinase binding(GO:0070696) activin receptor binding(GO:0070697) type II activin receptor binding(GO:0070699) |
0.5 | 10.0 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.5 | 4.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.4 | 2.2 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.4 | 1.8 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.4 | 0.9 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.4 | 4.8 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.4 | 3.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.4 | 1.7 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.4 | 3.4 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.4 | 1.7 | GO:0008494 | translation activator activity(GO:0008494) |
0.4 | 2.1 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.4 | 1.3 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.4 | 2.5 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.4 | 7.0 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.4 | 1.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.4 | 2.8 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.4 | 4.4 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.4 | 1.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.4 | 0.4 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.4 | 0.8 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.4 | 2.8 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.4 | 1.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.4 | 1.6 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.4 | 1.6 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.4 | 2.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.4 | 0.8 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
0.4 | 1.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.4 | 1.1 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.4 | 5.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.4 | 1.9 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.4 | 1.5 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.4 | 4.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.4 | 3.0 | GO:0039706 | co-receptor binding(GO:0039706) |
0.4 | 1.5 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.4 | 1.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium:inorganic phosphate symporter activity(GO:0015319) |
0.4 | 2.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.4 | 16.7 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.4 | 0.4 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.4 | 6.5 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.4 | 1.1 | GO:0009918 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
0.4 | 3.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.4 | 1.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.4 | 1.4 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
0.3 | 0.3 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.3 | 1.4 | GO:0019863 | IgE binding(GO:0019863) |
0.3 | 1.4 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
0.3 | 1.3 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.3 | 1.0 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.3 | 1.6 | GO:0000150 | recombinase activity(GO:0000150) |
0.3 | 2.6 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 5.2 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.3 | 2.6 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.3 | 2.6 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.3 | 2.9 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 1.6 | GO:0035173 | histone kinase activity(GO:0035173) |
0.3 | 0.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.3 | 3.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.3 | 0.6 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.3 | 1.5 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.3 | 0.9 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.3 | 1.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.3 | 0.9 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.3 | 1.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.3 | 0.9 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
0.3 | 1.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.3 | 1.5 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.3 | 1.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.3 | 2.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.3 | 1.8 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.3 | 1.2 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.3 | 6.7 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.3 | 4.0 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 4.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 0.9 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.3 | 4.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.3 | 0.8 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.3 | 3.6 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.3 | 9.5 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.3 | 1.1 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 1.7 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.3 | 3.0 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.3 | 1.1 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
0.3 | 0.8 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.3 | 0.8 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
0.3 | 1.9 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.3 | 0.8 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.3 | 1.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.3 | 5.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.3 | 1.9 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 3.0 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.3 | 0.8 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.3 | 2.4 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.3 | 8.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.3 | 1.6 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.3 | 1.1 | GO:0042731 | PH domain binding(GO:0042731) |
0.3 | 2.1 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 1.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 2.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 5.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.3 | 1.1 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.3 | 10.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 0.5 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.3 | 3.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 1.3 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.3 | 1.0 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.3 | 0.8 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.3 | 0.8 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.3 | 0.5 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.3 | 1.3 | GO:0046403 | polynucleotide 3'-phosphatase activity(GO:0046403) |
0.3 | 1.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.3 | 11.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.3 | 3.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.3 | 0.8 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.3 | 10.6 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.3 | 2.8 | GO:0046977 | TAP binding(GO:0046977) |
0.3 | 0.8 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.2 | 1.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 0.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.2 | 1.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.2 | 5.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 1.7 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.2 | 0.7 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.2 | 1.0 | GO:0050632 | propanoyl-CoA C-acyltransferase activity(GO:0033814) propionyl-CoA C2-trimethyltridecanoyltransferase activity(GO:0050632) phosphatidylethanolamine transporter activity(GO:1904121) |
0.2 | 1.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 1.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 0.5 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.2 | 2.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 0.9 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 0.7 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.2 | 2.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 10.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 1.4 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.2 | 3.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 9.5 | GO:0000049 | tRNA binding(GO:0000049) |
0.2 | 3.6 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 2.5 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.2 | 0.7 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 1.6 | GO:0031404 | chloride ion binding(GO:0031404) |
0.2 | 1.5 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.2 | 0.7 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.2 | 3.5 | GO:0030515 | snoRNA binding(GO:0030515) |
0.2 | 0.9 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 0.7 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.2 | 0.4 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.2 | 1.7 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.2 | 1.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 4.7 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.2 | 0.6 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.2 | 0.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 3.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 0.8 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.2 | 0.6 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.2 | 0.6 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 2.9 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.2 | 1.7 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.2 | 0.6 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.2 | 1.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 0.8 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 0.4 | GO:0032356 | oxidized DNA binding(GO:0032356) |
0.2 | 3.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 1.4 | GO:1901612 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
0.2 | 0.8 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 1.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 1.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.2 | 0.6 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.2 | 3.8 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 2.7 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.2 | 1.0 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.2 | 2.5 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 0.8 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.2 | 0.6 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 1.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 1.0 | GO:0099589 | serotonin receptor activity(GO:0099589) |
0.2 | 1.7 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.2 | 3.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 0.9 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 0.9 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 2.4 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 4.3 | GO:0031491 | nucleosome binding(GO:0031491) |
0.2 | 0.7 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.2 | 2.0 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 0.6 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.2 | 4.0 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 0.7 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.2 | 4.7 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.2 | 0.5 | GO:0031208 | POZ domain binding(GO:0031208) |
0.2 | 1.1 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.2 | 1.8 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.2 | 0.5 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 0.4 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.2 | 0.5 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.2 | 0.3 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.2 | 0.9 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.2 | 1.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 2.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 0.2 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.2 | 1.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.2 | 1.0 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.2 | 0.5 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.2 | 1.7 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.2 | 0.8 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 0.5 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.2 | 1.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 0.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.2 | 2.5 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 0.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.2 | 5.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 0.5 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.2 | 0.6 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
0.2 | 0.6 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 1.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.2 | 0.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 1.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 4.2 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.2 | 5.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 1.1 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.2 | 1.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 0.5 | GO:0031403 | lithium ion binding(GO:0031403) |
0.2 | 0.9 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.2 | 0.6 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.2 | 0.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 1.4 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.2 | 0.2 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.1 | 0.4 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.1 | 1.9 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.1 | 0.6 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.9 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.6 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 1.0 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 1.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 1.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.4 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.1 | 0.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 1.9 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 4.2 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 1.4 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 9.0 | GO:0008186 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 4.1 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 2.3 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.3 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.1 | 0.6 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.6 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.1 | 1.0 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 0.8 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 4.4 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 0.1 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.1 | 0.4 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
0.1 | 0.1 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 0.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.4 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.4 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.1 | 0.5 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 0.3 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.4 | GO:0051747 | cytosine C-5 DNA demethylase activity(GO:0051747) |
0.1 | 0.5 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.1 | 7.8 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 1.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 1.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 1.3 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.5 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.4 | GO:0043532 | angiostatin binding(GO:0043532) |
0.1 | 1.8 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 6.8 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.2 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 0.5 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 2.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 1.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 1.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.4 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.7 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 0.3 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.1 | 0.4 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 7.4 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.6 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.1 | 1.5 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.5 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 6.6 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 1.6 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 6.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.6 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.1 | 1.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.5 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 8.5 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 5.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 1.0 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
0.1 | 0.9 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 2.0 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.4 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.9 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.9 | GO:0023023 | MHC protein complex binding(GO:0023023) MHC class II protein complex binding(GO:0023026) |
0.1 | 0.4 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.4 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.1 | 0.8 | GO:0009055 | electron carrier activity(GO:0009055) |
0.1 | 1.5 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.1 | 0.3 | GO:0004482 | mRNA (guanine-N7-)-methyltransferase activity(GO:0004482) |
0.1 | 0.6 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 1.1 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 2.4 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.4 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.1 | 0.6 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.3 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.1 | 1.8 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 0.7 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 1.8 | GO:0030546 | receptor activator activity(GO:0030546) |
0.1 | 0.7 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.3 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 0.5 | GO:0016004 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.1 | 0.4 | GO:0036468 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
0.1 | 0.3 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.1 | 0.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.3 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.1 | 0.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.6 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.1 | 0.4 | GO:0050436 | microfibril binding(GO:0050436) |
0.1 | 0.3 | GO:0002054 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
0.1 | 1.0 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.1 | 0.8 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 1.0 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.9 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.5 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 1.2 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 0.2 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.3 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.3 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.2 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.1 | 0.2 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 3.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.3 | GO:0050347 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
0.1 | 0.2 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 0.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 2.3 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 1.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.8 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.4 | GO:1990188 | euchromatin binding(GO:1990188) |
0.1 | 0.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.1 | 0.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.5 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 0.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 3.3 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.1 | 0.9 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 1.1 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.5 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 0.2 | GO:0004454 | ketohexokinase activity(GO:0004454) |
0.1 | 0.1 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.1 | 0.2 | GO:0018738 | S-formylglutathione hydrolase activity(GO:0018738) |
0.1 | 2.2 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.1 | 0.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.9 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.1 | 0.3 | GO:0034041 | lipid-transporting ATPase activity(GO:0034040) sterol-transporting ATPase activity(GO:0034041) |
0.1 | 3.1 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.1 | 0.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 2.1 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 1.1 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.7 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.8 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.1 | 2.0 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.3 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 5.4 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.1 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 1.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 1.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 1.6 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.1 | 0.7 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.2 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.1 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.1 | 1.2 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.1 | 0.2 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.1 | 0.5 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.1 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.2 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.1 | 0.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.4 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 0.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.2 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.1 | 1.6 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.1 | 0.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.3 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.4 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 1.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 1.0 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.6 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 1.3 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.1 | 0.9 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 13.9 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.3 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.0 | 0.0 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 1.2 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 1.0 | GO:0004527 | exonuclease activity(GO:0004527) |
0.0 | 0.0 | GO:0043176 | amine binding(GO:0043176) |
0.0 | 0.3 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.0 | 0.2 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
0.0 | 0.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.5 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 2.3 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 0.9 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 1.3 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 3.3 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.3 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.1 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.0 | 0.0 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.2 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.3 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.1 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.0 | 1.1 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.2 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.3 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 1.0 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.4 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.0 | 0.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.5 | GO:0016853 | isomerase activity(GO:0016853) |
0.0 | 0.1 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.0 | 0.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.1 | GO:0070905 | serine binding(GO:0070905) |
0.0 | 0.3 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.1 | GO:0004875 | complement receptor activity(GO:0004875) |
0.0 | 0.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.1 | GO:0070736 | protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) |
0.0 | 0.9 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.8 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.8 | GO:0020037 | heme binding(GO:0020037) |
0.0 | 0.3 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.0 | 0.2 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.0 | 0.5 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.2 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.1 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.0 | 0.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.0 | 0.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.0 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.5 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 0.1 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.1 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.0 | 0.2 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.2 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.1 | GO:0003979 | UDP-glucose 6-dehydrogenase activity(GO:0003979) |
0.0 | 0.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.4 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.0 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) lipoprotein particle receptor activity(GO:0030228) |
0.0 | 0.5 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.4 | GO:0051287 | NAD binding(GO:0051287) |
0.0 | 0.0 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.0 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.1 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.1 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.0 | 2.0 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.1 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.0 | 0.1 | GO:0004104 | cholinesterase activity(GO:0004104) choline binding(GO:0033265) |
0.0 | 0.1 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.0 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.0 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.0 | 0.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 0.6 | PID_GMCSF_PATHWAY | GMCSF-mediated signaling events |
0.5 | 24.5 | PID_AURORA_B_PATHWAY | Aurora B signaling |
0.5 | 0.9 | ST_STAT3_PATHWAY | STAT3 Pathway |
0.4 | 0.9 | PID_ANTHRAX_PATHWAY | Cellular roles of Anthrax toxin |
0.4 | 0.4 | PID_LPA4_PATHWAY | LPA4-mediated signaling events |
0.4 | 12.1 | PID_NFKAPPAB_ATYPICAL_PATHWAY | Atypical NF-kappaB pathway |
0.4 | 13.5 | PID_AURORA_A_PATHWAY | Aurora A signaling |
0.4 | 8.6 | PID_IL27_PATHWAY | IL27-mediated signaling events |
0.4 | 5.7 | PID_ERB_GENOMIC_PATHWAY | Validated nuclear estrogen receptor beta network |
0.4 | 3.4 | SA_FAS_SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 10.4 | PID_MYC_PATHWAY | C-MYC pathway |
0.3 | 16.0 | PID_ATR_PATHWAY | ATR signaling pathway |
0.3 | 9.2 | PID_FOXM1_PATHWAY | FOXM1 transcription factor network |
0.3 | 9.7 | PID_WNT_SIGNALING_PATHWAY | Wnt signaling network |
0.3 | 5.8 | PID_LYMPH_ANGIOGENESIS_PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 1.9 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 29.2 | PID_MYC_ACTIV_PATHWAY | Validated targets of C-MYC transcriptional activation |
0.3 | 8.6 | PID_IL2_STAT5_PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 2.2 | SA_REG_CASCADE_OF_CYCLIN_EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.3 | 10.9 | PID_RET_PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.3 | 1.8 | ST_PAC1_RECEPTOR_PATHWAY | PAC1 Receptor Pathway |
0.2 | 0.9 | PID_NEPHRIN_NEPH1_PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 0.7 | PID_TCPTP_PATHWAY | Signaling events mediated by TCPTP |
0.2 | 4.2 | PID_FRA_PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 0.9 | SIG_IL4RECEPTOR_IN_B_LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 4.4 | PID_HEDGEHOG_2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 1.6 | PID_TCR_JNK_PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 7.9 | PID_PLK1_PATHWAY | PLK1 signaling events |
0.2 | 5.2 | PID_ALK1_PATHWAY | ALK1 signaling events |
0.2 | 2.3 | PID_PRL_SIGNALING_EVENTS_PATHWAY | Signaling events mediated by PRL |
0.2 | 2.6 | PID_INTEGRIN2_PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 4.5 | PID_IL6_7_PATHWAY | IL6-mediated signaling events |
0.2 | 4.3 | PID_BARD1_PATHWAY | BARD1 signaling events |
0.2 | 0.4 | PID_VEGFR1_PATHWAY | VEGFR1 specific signals |
0.2 | 6.4 | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 5.5 | NABA_PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 6.3 | PID_HNF3B_PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 1.0 | SA_PROGRAMMED_CELL_DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 0.3 | PID_NFAT_3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 2.9 | PID_HIF1A_PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 18.8 | NABA_ECM_REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 1.6 | PID_IL2_PI3K_PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 3.4 | PID_REG_GR_PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 5.8 | NABA_COLLAGENS | Genes encoding collagen proteins |
0.1 | 2.3 | PID_FCER1_PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 2.3 | PID_FANCONI_PATHWAY | Fanconi anemia pathway |
0.1 | 0.9 | PID_S1P_S1P2_PATHWAY | S1P2 pathway |
0.1 | 0.1 | PID_INTEGRIN4_PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 8.0 | PID_HDAC_CLASSI_PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.6 | PID_INTEGRIN_A9B1_PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 8.3 | PID_SMAD2_3NUCLEAR_PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 1.2 | PID_ECADHERIN_KERATINOCYTE_PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 4.6 | PID_RAC1_PATHWAY | RAC1 signaling pathway |
0.1 | 3.1 | PID_ARF6_PATHWAY | Arf6 signaling events |
0.1 | 2.4 | PID_FGF_PATHWAY | FGF signaling pathway |
0.1 | 1.0 | PID_SYNDECAN_2_PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.7 | PID_INTEGRIN5_PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 2.2 | PID_P38_ALPHA_BETA_PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.7 | PID_UPA_UPAR_PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 6.3 | PID_CMYB_PATHWAY | C-MYB transcription factor network |
0.1 | 1.2 | PID_INTEGRIN1_PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.6 | PID_TNF_PATHWAY | TNF receptor signaling pathway |
0.1 | 3.6 | PID_CERAMIDE_PATHWAY | Ceramide signaling pathway |
0.1 | 2.5 | PID_ALPHA_SYNUCLEIN_PATHWAY | Alpha-synuclein signaling |
0.1 | 1.9 | PID_HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 3.1 | PID_AJDISS_2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 2.2 | PID_DELTA_NP63_PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 1.0 | PID_SYNDECAN_1_PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 2.1 | PID_P38_MK2_PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 1.1 | PID_SYNDECAN_4_PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 4.1 | PID_ERA_GENOMIC_PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.4 | PID_CXCR4_PATHWAY | CXCR4-mediated signaling events |
0.1 | 1.4 | PID_AMB2_NEUTROPHILS_PATHWAY | amb2 Integrin signaling |
0.1 | 0.7 | PID_VEGF_VEGFR_PATHWAY | VEGF and VEGFR signaling network |
0.1 | 10.2 | NABA_ECM_GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.4 | PID_A6B1_A6B4_INTEGRIN_PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.2 | PID_THROMBIN_PAR1_PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 0.8 | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.9 | PID_E2F_PATHWAY | E2F transcription factor network |
0.1 | 1.5 | ST_B_CELL_ANTIGEN_RECEPTOR | B Cell Antigen Receptor |
0.1 | 0.8 | PID_RHODOPSIN_PATHWAY | Visual signal transduction: Rods |
0.1 | 1.4 | PID_AP1_PATHWAY | AP-1 transcription factor network |
0.1 | 2.6 | PID_CASPASE_PATHWAY | Caspase cascade in apoptosis |
0.1 | 1.2 | PID_IL1_PATHWAY | IL1-mediated signaling events |
0.1 | 0.1 | ST_JAK_STAT_PATHWAY | Jak-STAT Pathway |
0.1 | 0.9 | PID_ATF2_PATHWAY | ATF-2 transcription factor network |
0.1 | 0.4 | PID_TOLL_ENDOGENOUS_PATHWAY | Endogenous TLR signaling |
0.0 | 1.1 | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.1 | PID_IGF1_PATHWAY | IGF1 pathway |
0.0 | 0.1 | ST_ADRENERGIC | Adrenergic Pathway |
0.0 | 1.0 | PID_BMP_PATHWAY | BMP receptor signaling |
0.0 | 0.2 | PID_NECTIN_PATHWAY | Nectin adhesion pathway |
0.0 | 0.1 | SA_CASPASE_CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.4 | ST_ERK1_ERK2_MAPK_PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.1 | PID_PI3KCI_AKT_PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.4 | PID_NFAT_TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.1 | PID_SMAD2_3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.6 | PID_P53_REGULATION_PATHWAY | p53 pathway |
0.0 | 0.4 | PID_P75_NTR_PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.1 | PID_IL3_PATHWAY | IL3-mediated signaling events |
0.0 | 0.1 | PID_INTEGRIN3_PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.1 | PID_HDAC_CLASSII_PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.0 | ST_TUMOR_NECROSIS_FACTOR_PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 1.5 | NABA_SECRETED_FACTORS | Genes encoding secreted soluble factors |
Gene overrepresentation in C2:CP:REACTOME category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 18.7 | REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
1.3 | 10.2 | REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV1_INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
1.2 | 65.8 | REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
1.1 | 17.5 | REACTOME_UNWINDING_OF_DNA | Genes involved in Unwinding of DNA |
1.0 | 67.2 | REACTOME_PEPTIDE_CHAIN_ELONGATION | Genes involved in Peptide chain elongation |
0.8 | 0.8 | REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.7 | 36.7 | REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.7 | 7.0 | REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.7 | 6.7 | REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.6 | 11.0 | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.6 | 8.8 | REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.6 | 4.4 | REACTOME_ENDOGENOUS_STEROLS | Genes involved in Endogenous sterols |
0.6 | 5.6 | REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.6 | 3.1 | REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.6 | 43.1 | REACTOME_RESPIRATORY_ELECTRON_TRANSPORT | Genes involved in Respiratory electron transport |
0.6 | 7.2 | REACTOME_LAGGING_STRAND_SYNTHESIS | Genes involved in Lagging Strand Synthesis |
0.6 | 12.8 | REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_ | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.6 | 9.1 | REACTOME_PECAM1_INTERACTIONS | Genes involved in PECAM1 interactions |
0.6 | 7.8 | REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.5 | 9.2 | REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.5 | 5.9 | REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.5 | 0.5 | REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.5 | 1.1 | REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX | Genes involved in Assembly of the pre-replicative complex |
0.5 | 2.5 | REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.5 | 5.4 | REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.5 | 10.1 | REACTOME_SIGNAL_ATTENUATION | Genes involved in Signal attenuation |
0.5 | 5.3 | REACTOME_PURINE_CATABOLISM | Genes involved in Purine catabolism |
0.5 | 12.5 | REACTOME_KINESINS | Genes involved in Kinesins |
0.4 | 5.4 | REACTOME_G0_AND_EARLY_G1 | Genes involved in G0 and Early G1 |
0.4 | 2.6 | REACTOME_COMMON_PATHWAY | Genes involved in Common Pathway |
0.4 | 0.8 | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.4 | 9.5 | REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.4 | 1.2 | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.4 | 1.5 | REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.4 | 5.6 | REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.4 | 20.9 | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.4 | 2.2 | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.4 | 17.3 | REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT | Genes involved in Mitochondrial Protein Import |
0.3 | 1.7 | REACTOME_INTRINSIC_PATHWAY | Genes involved in Intrinsic Pathway |
0.3 | 9.7 | REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.3 | 3.4 | REACTOME_G1_S_SPECIFIC_TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.3 | 38.5 | REACTOME_MRNA_SPLICING | Genes involved in mRNA Splicing |
0.3 | 6.3 | REACTOME_RNA_POL_I_PROMOTER_OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.3 | 3.3 | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 10.4 | REACTOME_TIGHT_JUNCTION_INTERACTIONS | Genes involved in Tight junction interactions |
0.3 | 4.4 | REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.3 | 4.9 | REACTOME_P38MAPK_EVENTS | Genes involved in p38MAPK events |
0.3 | 9.4 | REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.3 | 0.3 | REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.3 | 6.9 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 9.8 | REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.3 | 2.3 | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.3 | 2.0 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.3 | 0.3 | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.3 | 0.6 | REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.3 | 2.5 | REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.3 | 1.9 | REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS | Genes involved in Activation of ATR in response to replication stress |
0.3 | 0.3 | REACTOME_INFLUENZA_LIFE_CYCLE | Genes involved in Influenza Life Cycle |
0.3 | 4.5 | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.3 | 5.5 | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS | Genes involved in Regulation of gene expression in beta cells |
0.3 | 6.4 | REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.3 | 6.3 | REACTOME_STRIATED_MUSCLE_CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 2.6 | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.2 | 1.7 | REACTOME_EXTENSION_OF_TELOMERES | Genes involved in Extension of Telomeres |
0.2 | 1.9 | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.2 | 12.3 | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 7.5 | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.2 | 4.0 | REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 2.0 | REACTOME_P2Y_RECEPTORS | Genes involved in P2Y receptors |
0.2 | 1.1 | REACTOME_PACKAGING_OF_TELOMERE_ENDS | Genes involved in Packaging Of Telomere Ends |
0.2 | 9.7 | REACTOME_METABOLISM_OF_NON_CODING_RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 0.4 | REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.2 | 0.4 | REACTOME_BASE_EXCISION_REPAIR | Genes involved in Base Excision Repair |
0.2 | 3.1 | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.2 | 0.2 | REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.2 | 0.2 | REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.2 | 2.8 | REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 9.3 | REACTOME_TRANSLATION | Genes involved in Translation |
0.2 | 6.5 | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 7.3 | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 1.2 | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 4.3 | REACTOME_G1_PHASE | Genes involved in G1 Phase |
0.2 | 2.5 | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 1.5 | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.2 | 2.5 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 2.9 | REACTOME_METABOLISM_OF_POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 1.6 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PS | Genes involved in Acyl chain remodelling of PS |
0.2 | 1.4 | REACTOME_BASIGIN_INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 8.3 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 6.5 | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.2 | 1.8 | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 1.5 | REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 3.6 | REACTOME_ENOS_ACTIVATION_AND_REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 6.1 | REACTOME_GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 3.0 | REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 0.2 | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.2 | 1.8 | REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 0.9 | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 2.4 | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.0 | REACTOME_PYRIMIDINE_CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 0.3 | REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 2.8 | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.4 | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 2.9 | REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 7.5 | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | Genes involved in Extracellular matrix organization |
0.1 | 1.4 | REACTOME_PYRIMIDINE_METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 0.5 | REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 1.1 | REACTOME_SIGNALING_BY_FGFR3_MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 0.5 | REACTOME_ETHANOL_OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 1.0 | REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.9 | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 3.3 | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.2 | REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.1 | 7.8 | REACTOME_MITOTIC_PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 2.2 | REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 1.6 | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 1.6 | REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.6 | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 0.5 | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 1.2 | REACTOME_MEIOSIS | Genes involved in Meiosis |
0.1 | 1.4 | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.5 | REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 1.4 | REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 2.1 | REACTOME_METABOLISM_OF_PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 5.1 | REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 1.1 | REACTOME_GAP_JUNCTION_ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.5 | REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 3.2 | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 2.8 | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 2.1 | REACTOME_CHOLESTEROL_BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.8 | REACTOME_TRYPTOPHAN_CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.5 | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.7 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 0.7 | REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 1.0 | REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.3 | REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 0.6 | REACTOME_REGULATION_OF_IFNG_SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 0.2 | REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 1.3 | REACTOME_TRNA_AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 0.1 | REACTOME_REGULATION_OF_AMPK_ACTIVITY_VIA_LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 0.6 | REACTOME_AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.3 | REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.1 | 1.8 | REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 0.6 | REACTOME_PYRUVATE_METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 0.5 | REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 1.5 | REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 1.1 | REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 6.8 | REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.5 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.2 | REACTOME_REGULATION_OF_COMPLEMENT_CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 2.4 | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 8.9 | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.5 | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 2.2 | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.0 | 0.1 | REACTOME_SYNTHESIS_OF_PE | Genes involved in Synthesis of PE |
0.0 | 0.3 | REACTOME_ACTIVATION_OF_GENES_BY_ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.6 | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.6 | REACTOME_METAL_ION_SLC_TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.2 | REACTOME_HDL_MEDIATED_LIPID_TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.3 | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 1.3 | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.1 | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.7 | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.6 | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.3 | REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.7 | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.0 | REACTOME_IRAK1_RECRUITS_IKK_COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.2 | REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.2 | REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.2 | REACTOME_MUSCLE_CONTRACTION | Genes involved in Muscle contraction |
0.0 | 0.2 | REACTOME_PURINE_METABOLISM | Genes involved in Purine metabolism |